首页 产品目录 分子砌块 按官能团 试剂 7-羟基-8b-(2-羟基乙酰基)-6a,8a-二甲基-10-丙基-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-十二氢-4H-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烷-4-酮

7-羟基-8b-(2-羟基乙酰基)-6a,8a-二甲基-10-丙基-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-十二氢-4H-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烷-4-酮

7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

51372-29-3

中文名称

7-羟基-8b-(2-羟基乙酰基)-6a,8a-二甲基-10-丙基-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-十二氢-4H-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烷-4-酮

英文名称

7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one

别名

Dexbudesonide | R-Budesonide | 51372-29-3 | Dexbudesonide [INN] | 51333-22-3 | 2HI1006KPH | Pregna-1,4-diene-3,20-dione,16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11b,16a)- | (1~{s},2~{s},4~{r},6~{r},8~{s},9~{s},11~{s},12~{s},13~{r})-9,13-Dimethyl-11-Oxidanyl-8

标准英文名

7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one

分子式

C25H34O6

分子量

430.54

精确分子量

430.24

SMILES

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1

标准SMILES

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO

用途

Budesonide is a glucocorticoid with potent local anti-inflammatory and anti-allergic activity, primarily used as an inhaled corticosteroid for the prevention and treatment of asthma and allergic rhinitis. It enhances the stability of endothelial cells, smooth muscle cells, and lysosomal membranes; inhibits immune responses and antibody synthesis; reduces the release and activity of allergic mediators such as histamine; and suppresses the enzyme-mediated processes triggered by antigen-antibody interactions, thereby inhibiting the synthesis and release of bronchoconstrictive substances and alleviating smooth muscle contraction. Due to its high first-pass hepatic metabolism (~85–90%) and low systemic bioavailability, budesonide exerts strong local anti-inflammatory effects in the airways with minimal systemic side effects, making it particularly suitable for pediatric use.

InChIKey

VOVIALXJUBGFJZ-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  51372-29-3 逆合成路线 1

—
—
ACHOIN389
51372-29-3
来源: SureRoute

2.  51372-29-3 逆合成路线 2

—
—
ACHOIN389
51372-29-3
来源: SureRoute

3.  51372-29-3 逆合成路线 3

—
—
ACHOIN389
51372-29-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手